secwatch.observer — SEC 8-K summary
======================================

Issuer:     SANUWAVE Health, Inc. (SNWV)
CIK:        0001417663
Form:       8-K
Filed at:   2025-06-03T23:59:59+00:00
Accession:  0001628280-25-029114
Event type: leadership
Sentiment:  neutral
Materiality: 0.50
Item codes: 5.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Sanuwave terminates CCO Nanci Gilmore, appoints Dustin Libby as EVP of Commercial Operations
--------------------------------------------------------------------------------

- Nanci Gilmore terminated without cause as CCO on May 30, 2025; eligible for $97,916.67 severance (5 months salary) subject to release.
- Dustin Libby appointed EVP of Commercial Operations effective June 3, 2025; brings 20 years of medical device experience.
- Libby previously at Abiomed, where he helped scale a $15M surgical business to over $500M in revenue.
- CEO Morgan Frank cited Libby's experience in scaling teams and systems for the next growth phase.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1417663/000162828025029114/0001628280-25-029114-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1417663/000162828025029114/snwv-20250530.htm
  HTML page:      https://secwatch.observer/filing/0001628280-25-029114

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer